Medical treatment of ovarian germ cell malignancies in the adult;Traitement medical des tumeurs germinales malignes de l'ovaire de l'adulte

Bulletin du Cancer

Volumn 84, Issue 9, 1997, Pages 919-921

  Culine, Stéphane ^a   Lhommé, Catherine ^b   Droz, Jean Pierre ^c  

^a CENTRE VAL D AURELLE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

chemotherapy; germ cell tumors; ovary

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; BEP PROTOCOL; PVB PROTOCOL; VINBLASTINE;

CHEMOTHERAPY; GERM CELL TUMOR; HUMAN; OVARY CANCER; SHORT SURVEY; CANCER STAGING; FEMALE; MULTIMODALITY CANCER THERAPY; OVARY TUMOR; PATHOLOGY; RADIATION DOSE; REVIEW; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; GERMINOMA; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0031216752     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Gershenson DM. Current status of the management of malignant ovarian germ cell tumors. Cancer Bull 1990 ; 42 : 93-7.
2. Serov SF, Scully RE, Sobin U. Histological typing of ovarian tumors. In : World Health Organization, ed. International histological classification of tumors. Geneva, 1973.
3. Culine S, Kramar A, Biron P, Droz JP. Chemotherapy in adult germ cell tumors. Crit Rev Oncol Hematol 1996 ; 22 : 229-63.
4. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group study (a final report). Cancer 1985 ; 56 : 243-8.
5. Williams SD, Blessing J, Slayton R, Homesley H, Photopulos G. Ovarian germ cell tumors: adjuvant trials of the Gynecologic Oncology Group (absrr.). Proc Am Soc Clin Oncol 1990 ; 8 : 150.
6. Carlson RW, Sikic BI, Turbon MM, Ballon SC. Combination cisplatin, vinblastine and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary. J Clin Oncol 1983 ; 1 : 645-51.
7. De Palo G, Sambetti M, Pilotti S, et al. Non-dysgerminomatous tumors of the ovary treated with cisplatin, vinblastine and bleomycin : long term results. Gynecol Oncol 1992 ; 47 : 239-46.
8. Gershenson DM, Kavanagh JJ, Copeland U, et al. Treatment of malignant non-dysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin and cisplatin. Cancer 1986 ; 57 : 1731-7.
9. Taylor MN, Depetrillo AD, Turner AR. Vinblastine, bleomycin and cisplatin in malignant germ cell tumors of the ovary. Cancer 1985 ; 56 : 1341-9.
10. Williams SD, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin : a trial of the Gynecologic Oncology Group. J Clin Oncol 1994 ; 12 : 701-6.
11. Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L Cisplatin, vinblastine and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 1989 ; 111 : 22-7.
12. Culine S, Lhommé C, Kattan J, Duvillard P, Michel G, Droz JP. Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary. Eur J Cancer 1994 ; 30A : 1239-44.
13. Gershenson DM, Morris M, Cangir A, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990 ; 8 : 715-20.
14. Culine S, Kattan J, Lhommé C, et al. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant non-dysgerminomatous germ-cell tumors of the ovary. Gynecol Oncol 1994 ; 54 : 47-53.
15. Culine S, Lhommé C, Farhat F, Droz JP. Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary. Fur J Cancer 1996 ; 31A : 1890-1.
16. Gershenson DM, Wharton JT, Kline RV, Larson DM, Kavanagh JJ, Rutledge FN. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Cancer 1986 ; 58 : 2594-9.
17. Williams SD, Blessing JA, Hatch KD, Homesley HD. Chemotherapy of advanced dysgerminoma : trials of the Gynecologic Oncology Group. J Clin Oncol 1991 ; 9 : 1950-5.
18. Culine S, Lhommé C, Kattan J, et al. Cisplatin-based chemotherapy in dysgerminoma of the ovary : thirteen-year experience at the Institut Gustave-Roussy. Gynecol Oncol 1995 ; 58 : 344-8.
19. Culine S, Lhommé C, Michel G, Leclère J, Duvillard P, Droz JP. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at the Institut Gustave-Roussy. J Surg Oncol 1996 ; 62 : 40-5.
20. Williams SD, Blessing JA, Disaia PJ, Major FJ, Ball HG, Liao SY. Second-look laparotomy in ovarian germ cell tumors: the Gynecologic Oncology Group experience. Gynecol Oncol 1994 ; 52 : 287-91.
21. Culine S, Lhommé C, Kattan J, Michel G, Duvillard P, Droz JP. Pure malignant immature teratoma of the ovary : the role of chemotherapy and second-look surgery. Int J Gynecol Cancer 1995 ; 5 : 432-7.
22. Bower M, Fife K, Holden L, Paradinos FJ, Rustin GJS, Newlands ES. Chemotherapy for ovarian germ cell tumors. Eur J Cancer 1996 ; 32A : 593-7.
23. Culine S, Lhommé C, Kattan J, Michel G, Duvillard P, Droz JP. Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary : the Institut Gustave- Roussy experience. Gynecol Oncol 1997 ; 64 : 160-5
24. Schwartz PE, Chambers SK, Chambers JT, Kohorn E, McIntosh S. Ovarian germ cell malignancies : the Yale University experience. Gynecol Oncol 1992 ; 45 : 26-31.
25. Segelov E, Campbell J, Ng M, et al. Cisplatin-based chemotherapy for ovarian germ cell malignancies : the Australian experience. J Clin Oncol 1994 ; 12 : 378-4.
26. Culine S, Berton D, Rey A, Lhommé C, Guastalla JP, Droz JP. Prognostic factors for survival in chemotherapy-treated ovarian germ cell tumors (abstr.) Proc Am Soc Clin Oncol 1996 : 15 : 294.
27. Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988 ; 6 : 270-5.